Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Paclitaxel Neuropathy With Cryotherapy

NCT02230319 is registered in ClinicalTrials.gov with Medical Oncology & Hematology Associates of Northern Virginia as lead sponsor.

NCT NCT02230319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Paclitaxel Neuropathy With Cryotherapy
Lead sponsor
Medical Oncology & Hematology Associates of Northern Virginia
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2014
Completion date
March 31, 2017
Enrollment
39 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer